Nature Conference: Innovative Tissue Therapies from Bench to Bedside

Register for #NatconfTissue21, organized by Nature Communications, to hear from an international panel of speakers as they share their latest advancements in tissue engineering, gene therapy, cell therapy, and innovative clinical treatments.
Nature Conference: Innovative Tissue Therapies from Bench to Bedside

At an upcoming virtual Nature Conference, Innovative Tissue Therapies from Bench to Bedside, we will hear from scientists developing innovative pre-clinical approaches in the realm of gene therapy, cell therapy and tissue engineering. Similarly, clinical researchers will give their perspective on the application of the most promising innovative treatments in human patients. 

Event Details 
November 16-18, 2021
07:00 EST (New York) | 12:00 GMT (London) | 13:00 CST (Milan) | 20:00 CST (Shanghai)

Presented by: I.R.C.C.S Ospedale San Raffaele and Nature Communications

Register now and be sure to submit your abstract by the September 20th deadline!

Learn more

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Life Sciences > Biological Sciences > Biotechnology

Related Collections

With collections, you can get published faster and increase your visibility.

Pre-clinical drug discovery

We welcome studies reporting advances in the discovery, characterization and application of compounds active on biologically or industrially relevant targets. Examples include emerging screening technologies, the development of small bioactive compounds/peptides/proteins, and the elucidation of compound structure-activity relationships, target interactions and mechanism-of-action.

Publishing Model: Open Access

Deadline: Mar 31, 2024

Biomedical applications for nanotechnologies

Overall, there are still several challenges on the path to the clinical translation of nanomedicines, and we aim to bridge this gap by inviting submissions of articles that demonstrate the translational potential of nanomedicines with promising pre-clinical data.

Publishing Model: Open Access

Deadline: Mar 31, 2024